However, the recent study has reported that saliva AChE can be used as potential biomarkers to indicate the significant impairment of the cholinergic system and memory impairment in patients with Alzheimer's disease [31]. This evidence concerns the gene ACHE and early-onset autosomal dominant Alzheimer disease.